$HIMS - Heading to support! Hims & Hers Health, Inc.BATS:HIMSKalaGhaziThe positive reaction in after-hours trading was driven by HIMS's impressive earnings, with revenues nearing the $600 million mark. From a technical analysis perspective, all eyes are now on the 200-day Moving Average. The critical test will be whether the stock can successfully break through and reclaim this level from below. If it succeeds, the price would re-enter its former trading range, creating a promising setup for a future upward breakout. On the downside, a failure to overcome the 200-day MA could lead to a pullback. The most likely target in that scenario would be the $37.45 level, which aligns with the 0.618 Fibonacci retracement and has proven to be a reliable support zone in the past. My investment stance remains firmly long-term. The company's solid fundamentals, underscored by newly announced growth initiatives and a strategic global expansion into markets like Europe, Brazil, and Australia, provide strong conviction to hold through near-term price fluctuations. KalaGhazii Support and Resistance - Support - $37.50 - $40.00 Resistance - $60 - $65